Dublin, May 25, 2021 (GLOBE NEWSWIRE) -- The "Electroencephalography Devices Market Share, Size, Trends, Industry Analysis Report, By Modality; By Application; By Product; By End-Use; By Regions; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
The global electroencephalography (EEG) devices market size is expected to reach USD 1.83 billion by 2028 according to a new study.
The standalone segment dominated the global market for electroencephalography devices in 2020. However, the demand for portable EEG devices market is expected to increase during the forecast period. Portable electroencephalography (EEG) devices are increasingly being used in ambulatory centers and homecare of patients. Some benefits associated with the portable market segment include reduced costs, mobility, lightweight, shorter installation time, and reduced traveling for patients.
The different applications of electroencephalography devices include trauma and surgery, disease diagnosis, anesthesia monitoring, sleep monitoring, and others. Electroencephalography devices are increasingly being used for disease diagnoses such as brain tumors, brain damage from a head injury, brain dysfunction, inflammation of the brain, and strokes among others.
Electroencephalography devices enable doctors to diagnose the disease and determine the stage, plan treatment, and track treatment progress. The detailed information provided by these devices enables neurologists to offer an effective treatment.
The 32-channel EEG market segment dominated the global market for electroencephalography devices in 2020. The need for high scan speed, enhanced efficiency, and improved patient experience has increased the adoption of 32-channel EEG devices. The growing need to perform a neurological scan, increasing geriatric population, and rising healthcare expenditure in developing countries, such as India, China, and Japan, boost the adoption of electroencephalography systems.
Electroencephalography devices are used in hospitals, clinics, diagnostic centers, research laboratories, and others. The hospital market segment accounted for the highest share in 2020. The increasing occurrence of neurological diseases coupled with government initiatives to offer advanced healthcare services to citizens supports the growth of this segment. Availability of advanced equipment and financial funds, supportive government initiatives, and the introduction of medical schemes have increased the adoption of electroencephalography devices in hospitals.
North America dominated the global market for electroencephalography devices in 2020 and is expected to maintain its dominance over the forecast period. The rising occurrence of neurological diseases, availability of technologically advanced equipment, and presence of well-established healthcare infrastructure increase the demand for electroencephalography devices in North America.
Asia Pacific market is expected to experience significant growth during the forecast period owing to the growing population, increasing health awareness, and rising spending on healthcare. Leading global players are expanding their presence in developing nations of China, Japan, India, and South Korea to tap the growth opportunities offered by these countries.
Cadwell Laboratories Inc.
NeuroWave Devices Inc.
Electrical Geodesics Inc.
BrainScope Company Inc.
Natus Medical Inc.
Nihon Kohden America Inc.
Noraxon U.S.A. Inc.
Lifelines Neurodiagnostic Devices Inc.
Bio-Signal Group Corp.
Jordan NeuroScience Inc.
Electroencephalography (EEG) Devices Modality Outlook
Electroencephalography (EEG) Devices Application Outlook
Trauma & Surgery
Electroencephalography (EEG) Devices Product Outlook
Electroencephalography (EEG) Devices End-Use Outlook
For more information about this report visit https://www.researchandmarkets.com/r/32abdu
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900